PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
32268932-1	2020	Both standard and sustained-release injectable formulations of buprenorphine (Bup and BupSR, respectively) are used as preemptive analgesics, potentially affecting gas anesthetic requirements.	Buprenorphine	63-76	COMM domain containing 3	Mus musculus	78-81	
11303059-1	2001	Buprenorphine (BUP) is an oripavine analgesic that is beneficial in the maintenance treatment of opiate-dependent individuals.	Buprenorphine	0-13	COMM domain containing 3	Mus musculus	15-18	
32268932-2	2020	This study tested the effects of Bup and BupSRon isoflurane requirements and confirmed that buprenorphine could reduce isoflurane requirements during a laparotomy in mice.	Buprenorphine	92-105	COMM domain containing 3	Mus musculus	33-36	
26817982-1	2016	Mice purportedly require dosing with the opioid buprenorphine (Bup-HCl) at least every 8 to 12 h to maintain an adequate plane of analgesia.	Buprenorphine	48-61	COMM domain containing 3	Mus musculus	63-66	
26817982-2	2016	Here we used an experimental laparotomy model to determine the clinical efficacy of sustained-release formulations of buprenorphine (Bup-SR) after surgery in mice.	Buprenorphine	118-131	COMM domain containing 3	Mus musculus	133-136